EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement

Rana Alnasser Alsukhni iD, Ekawat Vichayanrat, Shiwen Koay, Laura May Davis, Gordon Ingle, Patricia McNamara, Jalesh N Panicker, Kailash P Bhatia, Christopher Mathias, Jamshed Bomanji, Valeria Iodice

European Journal of Neurology · 2024

DOI: 10.1111/ene.16169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Rana Alnasser Alsukhni und 10 weiteren Autor:innen. Beteiligte Einrichtung: Autonomic Unit, National Hospital for Neurology and Neurosurgery, London, UK. Hauptthemen laut MEDLINE: Pure Autonomic Failure, Multiple System Atrophy, Autonomic Nervous System Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose Pure autonomic failure (PAF) is a rare progressive neurodegenerative disease characterized by neurogenic orthostatic hypotension at presentation, without other neurological abnormalities. Some patients may develop other central neurological features indicative of multiple system atrophy or a Lewy body disorder. There are currently no biomarkers to assess possible central nervous system involvement in probable PAF at an early stage. A possibility is to evaluate the nigrostriatal dopaminergic degeneration by imaging of dopamine transporter with DaTscan brain imaging. The objective was to evaluate subclinical central nervous system involvement using DaTscan in PAF.

Methods

We retreospectively reviewed pure autonomic failure patients who were evaluated at the Autonomic Unit between January 2015 and August 2021 and underwent comprehensive autonomic assessment, neurological examination, brain magnetic resonance imaging and DaTscan imaging. DaTscan imaging was performed if patients presented with atypical features which did not meet the criteria for Parkinson's disease or multiple system atrophy or other atypical parkinsonism.

Results

In this cohort, the median age was 49.5 years at disease onset, 57.5 years at presentation, and the median disease duration was 7.5 years. Five of 10 patients had an abnormal DaTscan without neurological features meeting the criteria of an alternative diagnosis. Patients with abnormal DaTscan were predominantly males, had shorter disease duration and had more severe genitourinary symptoms.

Discussion

Degeneration of nigrostriatal dopaminergic neurons measured using DaTscan imaging can present in patients with PAF without concurrent signs indicating progression to widespread α‐synucleinopathy. It is advocated that DaTscan imaging should be considered as part of the workup of patients with emerging autonomic failure who are considered to have PAF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pure Autonomic FailureMultiple System AtrophyAutonomic Nervous System DiseasesMaleHumansMiddle AgedFemaleDopamine Plasma Membrane Transport ProteinsDopaminergic ImagingBrainBiomarkers

Stichwörter der Autor:innen

DaTscancentral involvementdopamine transporterphenoconversionpure autonomic failure

Substanzen

Dopamine Plasma Membrane Transport ProteinsBiomarkers

Autor:innen und Institutionen

  • Autonomic Unit, National Hospital for Neurology and Neurosurgery, London, UK.
  • Institute of Nuclear Medicine, UCLH NHS Foundation Trust, London, UK.
  • UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
  • Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.

ORCID-Profile: Rana Alnasser Alsukhni

Zitieren

APA

Alnasser Alsukhni, R., Vichayanrat, E., Koay, S., Davis, L. M., Ingle, G., McNamara, P., Panicker, J. N., Bhatia, K. P., Mathias, C., Bomanji, J., & Iodice, V. (2024). Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement. European Journal of Neurology. https://doi.org/10.1111/ene.16169

Vancouver

Alnasser Alsukhni R, Vichayanrat E, Koay S, Davis LM, Ingle G, McNamara P, et al. Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement. European Journal of Neurology. 2024. doi:10.1111/ene.16169

BibTeX
@article{AlnasserAlsukhni2024,
  author = {Alnasser Alsukhni, Rana and Vichayanrat, Ekawat and Koay, Shiwen and Davis, Laura May and Ingle, Gordon and McNamara, Patricia and Panicker, Jalesh N and Bhatia, Kailash P and Mathias, Christopher and Bomanji, Jamshed and Iodice, Valeria},
  title = {Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16169}
}
Kostenlos starten →